Helicobacter (2014) 19:528
When prescribed and supervised by a licensed medical provider and sourced from a regulated US compounding pharmacy, peptide therapy carries a strong safety profile

Standard AOD-9604 Dosing Protocol Subcutaneous Injection Dosing: Beginner: 250 mcg per dose, once daily Intermediate: 300-400 mcg per dose, once daily or divided into two doses Advanced: 500 mcg per dose, once daily or 250 mcg twice daily Oral Administration Dosing (if using oral formulation): Standard: 1-2 mg per dose, once daily on empty stomach Higher protocols: Up to 5-10 mg daily, as studied in clinical trials Frequency: Once daily (morning preferred) or twice daily (morning and early afternoon) Timing: Best administered on an empty stomach, typically upon waking or before exercise Cycle Length: 12-16 weeks for initial assessment, with potential for longer protocols based on response Off Cycle: 4-8 weeks between cycles, though not strictly required based on current research Note: Start at the lower end of the dosing range to assess individual tolerance

All BPC-157 prescriptions at Prime Vitality Care are evidence-informed and discussed thoroughly with each patient prior to treatment
During shortages of FDA-approved products containing semaglutide, such as Ozempic, compounded semaglutide has been available as an alternative option
Improper storage of tirzepatide can compromise the medication's molecular structure, leading to reduced efficacy or complete loss of therapeutic activity